Biosyntech Inc logo

BSYI - Biosyntech Inc Share Price

$0.01 0.0  0.0%

Last Trade - 01/03/21

Micro Cap
Market Cap £803k
Enterprise Value £9.81m
Revenue £115k
Position in Universe th / 6633
Unlock BSYI Revenue
Relative Strength (%)
1m +280%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -65.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2004 2005 2006 2007 2008 2009 2010E 2011E CAGR / Avg
0.24 0.18 0.062 0.24 0.27 0.041 -29.7%
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2009,BioSyntech, Inc. revenues increased from C$17K to C$176K.Net loss decreased 2% to C$9.7M. Revenues reflect anincrease in demand for the Company's products and servicesdue to favorable market conditions. Lower net loss reflectsResearch and development decrease of 41% to C$2.7M(expense), Restructuring costs decrease from C$1.4M(expense) to C$0K.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


BSYI Revenue Unlock BSYI Revenue

Net Income

BSYI Net Income Unlock BSYI Revenue

Normalised EPS

BSYI Normalised EPS Unlock BSYI Revenue

PE Ratio Range

BSYI PE Ratio Range Unlock BSYI Revenue

Dividend Yield Range

BSYI Dividend Yield Range Unlock BSYI Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
BSYI EPS Forecasts Unlock BSYI Revenue
Profile Summary

BioSyntech, Inc. is a development-stage company. The Company develops advanced biotherapeutic thermogels specifically designed for tissue repair and delivery of therapeutic agents. It focuses its efforts on the development of its lead program BST-CarGel, a natural biopolymer derived from the shells of crustaceans. Using its BST-Gel technology platform, BST-CarGel is being developed as a treatment for the regeneration of cartilage in the knee. BioSyntech is developing a first product for cartilage repair and it has reached clinical trial stage.

Last Annual March 31st, 2009
Last Interim December 31st, 2009
Incorporated December 15, 1994
Public Since January 10, 2000
No. of Shareholders: n/a
No. of Employees: 20
Sector Healthcare
Industry Healthcare Equipment & Supplies
Exchange Pink Sheets on Nasdaq
Shares in Issue 116,441,283
Free Float (0.0%)
Eligible for
BSYI Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for BSYI
Upcoming Events for BSYI
Frequently Asked Questions for Biosyntech Inc
What is the Biosyntech Inc share price?

As of 01/03/21, shares in Biosyntech Inc are trading at $0.01, giving the company a market capitalisation of £803k. This share price information is delayed by 15 minutes.

How has the Biosyntech Inc share price performed this year?

Shares in Biosyntech Inc are currently trading at $0.01 and the price has moved by 0.317k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biosyntech Inc price has moved by 0.233k% over the past year.

What are the analyst and broker recommendations for Biosyntech Inc?

There are no analysts currently covering Biosyntech Inc.

When will Biosyntech Inc next release its financial results?

Biosyntech Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2010-12-31
What is the Biosyntech Inc dividend yield?

Biosyntech Inc does not currently pay a dividend.

Does Biosyntech Inc pay a dividend?

Biosyntech Inc does not currently pay a dividend.

When does Biosyntech Inc next pay dividends?

Biosyntech Inc does not currently pay a dividend.

How do I buy Biosyntech Inc shares?

To buy shares in Biosyntech Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Biosyntech Inc?

Shares in Biosyntech Inc are currently trading at $0.01, giving the company a market capitalisation of £803k.

Where are Biosyntech Inc shares listed? Where are Biosyntech Inc shares listed?

Here are the trading details for Biosyntech Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: BSYI
What kind of share is Biosyntech Inc?

We were not able to load our ranking data for Biosyntech Inc

Is there a Biosyntech Inc share price forecast 2021?

We were not able to load any forecast data for Biosyntech Inc.

How can I tell whether the Biosyntech Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biosyntech Inc. Over the past six months, the relative strength of its shares against the market has been 0.178k%. At the current price of $0.01, shares in Biosyntech Inc are trading at 0.127k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Biosyntech Inc PE Ratio?

We were not able to find PE ratio data for Biosyntech Inc.

Who are the key directors of Biosyntech Inc?

Biosyntech Inc's management team is headed by:

Jeanne Bertonis - CEO
Catherine Auld - CFO
Who are the major shareholders of Biosyntech Inc?

Here are the top five shareholders of Biosyntech Inc based on the size of their shareholding:

Similar to BSYI
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.